Miltefosine in visceral leishmaniasis.
Olliaro
Piero L
PL
Ridley
Robert G
RG
Engel
Jurgen
J
Sindermann
Herbert
H
Bryceson
Anthony D M
AD
D000818:Animals; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D005298:Fertility / Q000187:drug effects*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D010767:Phosphorylcholine / Q000009:adverse effects* / Q000031:analogs & derivatives*
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine